로딩 중…
지수 로딩 중…
휴온스
243070· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩26,150-4.04%
2026-06-19
Price Chart
휴온스-7.76%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 313.27B KRW |
| Revenue | 616.80B KRW |
| Net Income | 30.13B KRW |
| Net Assets | 408.03B KRW |
| Employees | 1,049 |
| Value | |
| P/E | 10.40x |
| P/B | 0.77x |
| P/S | 0.51x |
| EV/EBITDA | 13.22x |
| FCF Yield | 5.60% |
| Profitability | |
| ROE | 7.38% |
| Op. Margin | 5.21% |
| Revenue Growth | -2.72% |
| Earnings Growth | -98.45% |
| Financial Health | |
| Debt Ratio | 162.08% |
| Total Debt | 166.70B KRW |
| FCF | 17.54B KRW |
| Cash | 55.46B KRW |
| Current Ratio | 1.52x |
| Net Debt/EBITDA | 3.46x |
| Dividend | |
| Div. Yield | 3.38% |
| Div. Growth | 46.03% |
| Performance | |
| 1Y Return | -7.76% |
| 1M Return | -26.96% |
| From 52W High | -36.99% |
| 1Y MDD | -31.54% |
| Trading | |
| Volume | 23,809 shares |
| Foreign Own. | 15.85% |
| Per Share | |
| EPS | 2,562 KRW |
| BPS | 31,800 KRW |
Company Info
Founded in 1965, the company re-listed on KOSDAQ in 2016 following a spin-off from Huons Global. It holds stakes in Huons N (health functional food company), Huons BioScience (pharmaceutical manufacturing), and PanGen (biosimilar EPO producer), which are slated for subsidiary incorporation in 2025. The professional pharmaceutical business supplies various professional pharmaceuticals domestically, while its beauty and well-being business expands into well-being pharmaceuticals, obesity treatments, medical devices, and health functional foods. Huons was established in 2016 and is headquartered in Seongnam-si, Gyeonggi-do.